BioSpace News Archive

Allogene Therapeutics, Inc. today announced the appointment of Jae Park, M.D., acting Chief of Cellular Therapeutics at Memorial Sloan Kettering Cancer Center in New York, to its Scientific Advisory Board (SAB).

Aadi Bioscience, Inc. today announced the appointment of Brendan Delaney to the role of Chief Operating Officer (COO).

The Foundation for Sarcoidosis Research, the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is proud to bring together global experts, physicians, and ancillary staff to share best practices in sarcoidosis clinical care at the first-ever virtual Clinical Engagement Conference: Bridging the Gap for a Brighter Future this October.

Enveric Biosciences, a biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform for the mind and body using psychedelics and cannabinoids, announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in two upcoming investor conferences.

Orthofix Medical Inc. today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in a fireside chat during the upcoming Sidoti Virtual Investor Conference on Thursday, September 23, 2021 at 2:30 p.m. ET.

BeiGene added to FTSE Global Equity Index Large Cap, All-World (LM), All-Cap (LMS), Total-Cap (LMSµ); as well as the Developed ESG Low Carbon Select Index and Asia ex Japan ESG Low Carbon Select Index

Mindset Pharma Inc. today announced that preclinical proof-of-concept data comparing its clinical candidate, MSP-4018, against 5-MeO-DMT

BeyondSpring today will have a late-breaking oral presentation at the European Society for Medical Oncology 2021 Congress.

PsyBio Therapeutics Corp. today announced that Evan Levine , Chief Executive Officer and Chairman, will participate in the Maxim Group Advances in Mental Health Virtual Conference and the Benzinga Virtual Global Healthcare Small Cap Conference in September 2021.

Benitec Biopharma Inc. announced the financial results for its fiscal year ended June 30, 2021.